Psoriasis‐like eruptions developed in an atopic dermatitis patient treated with dupilumab

Abstract

This study investigates the development of psoriasis‐like eruptions from dupilumab treatment. Our case suggests that psoriasis‐like eruptions might occur during dupilumab treatment, particularly in Asians, and requires careful follow‐up. We believe that our study makes a significant contribution to the literature as it highlights a potential adverse effect of this treatment for atopic dermatitis.

Dupilumab‐induced psoriasiform dermatitis in two pediatric cardiac transplant patients

“…4 Risk factors for dupilumab-induced psoriasiform dermatitis are poorly studied to date but are thought to include Asian ethnicity and abnormal immunologic response to skin flora. 5,6 Psoriasiform dermatitis following dupilumab therapy has previously been reported in children, adults, and adults with organ transplantation on immunosuppressive therapy. [7][8][9] Pediatric patients with dupilumab-induced psoriasiform dermatitis tend to have less severe and less refractory disease compared to adults, with many able to continue dupilumab long-term and manage their psoriasiform lesions with topical agents alone.…”